Our Work
-

VVT Medical Inc.
Principals at I3 Capital advised ExitTeam Acquisition Corporation on it’s acquisition of VVT Medical in furtherance of a Reverse Takeover on the TSX Venture Exchange
VVT is a manufacturer of varicose vein treatment devices that have completed 3,800+ procedures with no reported pain or complications. Approved for use in the USA, EU, India, Australia, Korea and the UAE. $30MM in distribution agreements over 5 years.
VVTM:TSXV
-

Eshbal Functional Food
I3 was engaged to generate market awareness 6 months after the company was listed on the TSXV.
Eshbal is a New York and Israel-based gluten-free and vegan food company with 300 SKU’s and distribution in Walmart and 500+ other locations
ESBL:TSXV
-

GreenData Centers Inc
Principals at I3 Capital are advising the senior leadership team at GreenData Centers including raising equity & debt capital for it’s initial property site acquisition and subsequent transactions with Hyperscaler clients
Pursuing listing on NASDAQ
-

NurExone Biologic
I3 Capital and Foundation Markets Inc are advising the company (TSXV: NRX) and are a joint book runner for the company’s new equity offering.
NRX:TSXV